Patents by Inventor Anne Voss

Anne Voss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF HMB TO IMPROVE QUALITY OF LIFE FOR HOSPITALIZED PATIENTS
    Publication number: 20160106131
    Abstract: A method of care is described that includes administering an effective amount of ?-hydroxy-?-methylbutyrate (HMB) to an adult or elderly patient to improve the patient's quality of life during or after hospitalization of the patient. The improved quality of life may encompass the general health, physical health, or mental health of the patient.
    Type: Application
    Filed: December 29, 2015
    Publication date: April 21, 2016
    Applicant: ABBOTT LABORATORIES
    Inventors: Menghua LUO, Jeffrey NELSON, Anne VOSS, Owen KELLY, Geraldine BAGGS, Min TIAN, Jamie PARTRIDGE
  • HMB compositions and uses thereof
    Publication number: 20070093553
    Abstract: The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ?-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and substantially lacking in free amino acids.
    Type: Application
    Filed: December 29, 2004
    Publication date: April 26, 2007
    Inventors: Jeffrey Baxter, Pradip Mukerji, Anne Voss, Michael Tisdale
  • HMB compositions and uses thereof
    Publication number: 20050215640
    Abstract: The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ?-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and subtantially lacking in free amino acids.
    Type: Application
    Filed: March 26, 2004
    Publication date: September 29, 2005
    Inventors: Jeffrey Baxter, Pradip Mukerji, Anne Voss, Michael Tisdale